Advanced or Metastatic Solid Tumor Completed Phase 1 Trials for SF1126 (DB05210)

Also known as: Advanced / Metastatic Solid Tumor / Advanced/Metastatic Solid Tumor / Advanced and Metastatic Solid Tumor / Metastatic and Advanced Solid Tumors / Advanced and/or Metastatic Solid Tumors / Advanced or Metastatic Solid Tumors / Advanced / Metastatic Solid Tumors / Advanced/ Metastatic Solid Tumors / Advanced/Metastatic Solid Tumors

IndicationStatusPhase
DBCOND0109909 (Advanced or Metastatic Solid Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00907205A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid TumorsTreatment